Precision livestock technologies offer earlier diagnosis of calf-killing bovine respiratory disease

The proportion of RNs planning to leave their position fell from 2022 to 2023, though planned departure rates, abusive or violent events, and unsafe conditions

The high-dose ver­sion of Re­gen­eron’s eye treat­ment Eylea hit its pri­ma­ry end­point in a late-stage study for mac­u­lar ede­ma fol­low­ing reti­nal vein oc­clu­sion, a com­mon